Open AccessAn exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
Author(s) -
Vikas Talreja,
Vanita Noronha,
Amit Joshi,
Vijay Patil,
Kumar Prabhash
Publication year - 2020
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/sajc.sajc_157_19
Subject(s) - medicine , olaparib , ovarian cancer , license , oncology , paclitaxel , cancer research , cancer , genetics , gene , polymerase , political science , law , poly adp ribose polymerase , biology